Pieternella Johanna Lugtenburg

机构：Erasmus MC Cancer Institute · ORCID：0000-0002-6735-8651

发表论文 291 篇 · 总被引 10809 次 · h-index 49

代表论文

• Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study (2024 · The Lancet Haematology · 被引 166)
• Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial (2024 · Leukemia · 被引 143)
• Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial (2025 · Blood · 被引 62)
• Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort (2023 · Blood · 被引 38)
• Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma (2024 · Journal of Clinical Oncology · 被引 37)
• Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands (2024 · Blood Cancer Journal · 被引 23)